{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:24:11Z","timestamp":1788791051819,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant Fondecyt","award":["1150194"],"award-info":[{"award-number":["1150194"]}]},{"name":"University San Sebasti\u00e1n Chile"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pnpbp.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T06:15:43Z","timestamp":1495260943000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice"],"prefix":"10.1016","volume":"78","author":[{"given":"J. Alex","family":"Grizzell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-1971","authenticated-orcid":false,"given":"George E.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.05.010_bb0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","article-title":"Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice","volume":"17","author":"Arendash","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(00)03186-3","article-title":"Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes","volume":"891","author":"Arendash","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.02.081","article-title":"Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain","volume":"1012","author":"Arendash","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0020","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/sj.emboj.7600251","article-title":"PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations","volume":"23","author":"Baki","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","article-title":"A beta-arrestin 2 signaling complex mediates lithium action on behavior","volume":"132","author":"Beaulieu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/156720511796717195","article-title":"Tau as a therapeutic target for Alzheimer's disease","volume":"8","author":"Boutajangout","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrd2959","article-title":"Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies","volume":"8","author":"Brunden","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0040","doi-asserted-by":"crossref","first-page":"T466","DOI":"10.1016\/j.jalz.2008.05.1396","article-title":"Cotinine is neuroprotective against beta-amyloid toxicity","volume":"4","author":"Burgess","year":"2008","journal-title":"J. Alzheimer's Assoc."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1755-5949.2009.00086.x","article-title":"Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium","volume":"15","author":"Camins","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnbeh.2010.00177","article-title":"The formation and stability of recognition memory: what happens upon recall?","volume":"4","author":"Davis","year":"2010","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0055","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hbm.21102","article-title":"Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer","volume":"32","author":"de Ruiter","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-2012-120805","article-title":"Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study","volume":"33","author":"del Ser","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0065","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.neurobiolaging.2014.04.031","article-title":"PERK mediates eIF2alpha phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease","volume":"35","author":"Devi","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0070","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1523\/JNEUROSCI.1429-16.2016","article-title":"Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer's disease pathology and improves cognition in the 5XFAD mouse","volume":"36","author":"Dinkins","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/jbc.M111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase kinase-3beta by tideglusib","volume":"287","author":"Dominguez","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075025","article-title":"Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases","volume":"8","author":"Duka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0085","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuroscience.2009.05.019","article-title":"Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice","volume":"162","author":"Echeverria","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1385\/MN:26:2-3:299","article-title":"Intracellular A-beta amyloid, a sign for worse things to come?","volume":"26","author":"Echeverria","year":"2002","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2004-6301","article-title":"Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex","volume":"6","author":"Echeverria","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuroscience.2004.07.036","article-title":"Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons","volume":"129","author":"Echeverria","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pneurobio.2016.01.002","article-title":"Positive modulators of the \u03b17 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease","volume":"144","author":"Echeverria","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1755-5949.2012.00317.x","article-title":"Cotinine: a potential new therapeutic agent against Alzheimer's disease","volume":"18","author":"Echeverria","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-2011-102136","article-title":"Cotinine reduces amyloid-beta aggregation and improves memory in Alzheimer's disease mice","volume":"24","author":"Echeverria","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-2011-102136","article-title":"Cotinine reduces amyloid-beta aggregation and improves memory in Alzheimer's disease mice","volume":"24","author":"Echeverria","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-8-2","article-title":"Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta 42 accumulation and caspase-3 activation","volume":"8","author":"Eimer","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0130","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1523\/JNEUROSCI.0604-06.2006","article-title":"Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3","volume":"26","author":"Engel","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.freeradbiomed.2013.11.014","article-title":"Antisense oligonucleotide against GSK-3beta in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer disease","volume":"67","author":"Farr","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nlm.2014.12.014","article-title":"The integrated role of ACh, ERK and mTOR in the mechanisms of hippocampal inhibitory avoidance memory","volume":"119C","author":"Giovannini","year":"2015","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0150","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.nbd.2009.11.017","article-title":"Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits","volume":"37","author":"Gomez de Barreda","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroscience.2010.03.032","article-title":"Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels","volume":"167","author":"Goulart","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbr.2014.03.047","article-title":"Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice","volume":"268","author":"Grizzell","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0165","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.neurobiolaging.2012.01.015","article-title":"Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia","volume":"33","author":"Guadagna","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-130545","article-title":"Microtubule depolymerization and tau phosphorylation","volume":"37","author":"Hernandez","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.25815","article-title":"Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial","volume":"29","author":"Hoglinger","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0180","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11481-012-9417-5","article-title":"Wnt signaling: role in Alzheimer disease and schizophrenia","volume":"7","author":"Inestrosa","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/14728222.2014.870156","article-title":"Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease","volume":"18","author":"Iqbal","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fneur.2013.00112","article-title":"Hyperphosphorylation-induced tau oligomers","volume":"4","author":"Iqbal","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jnc.12821","article-title":"Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice","volume":"132","author":"Ittner","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuroscience.2004.09.055","article-title":"Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging","volume":"130","author":"Jensen","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0210","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/ejn.12504","article-title":"Tau acts as a mediator for Alzheimer's disease-related synaptic deficits","volume":"39","author":"Liao","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0215","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.25584","article-title":"Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma","volume":"55","author":"Liu","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.010_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of Tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12035-013-8425-7","article-title":"Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway","volume":"48","author":"Lucas","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0235","first-page":"46","article-title":"GSK-3beta, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Martin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2003.04.007","article-title":"Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses","volume":"24","author":"Mandelkow","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00401-013-1230-6","article-title":"The neuropathology of sport","volume":"127","author":"McKee","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0250","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WCO.0000000000000107","article-title":"Update on SPECT and PET in parkinsonism - part 2: biomarker imaging of cognitive impairment in Lewy-body diseases","volume":"27","author":"Meyer","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nan.12084","article-title":"Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome","volume":"40","author":"Mondragon-Rodriguez","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0260","article-title":"Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?","volume":"276803","author":"Mondragon-Rodriguez","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.12.001","article-title":"Thr-phosphorylated tau induces pathologic fibril formation via GSK3beta-mediated phosphorylation of Thr in vitro","author":"Moszczynski","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","article-title":"Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease","volume":"110","author":"Nagele","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0275","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0166-2236(00)01872-5","article-title":"CREB and the enhancement of long-term memory","volume":"24","author":"Nguyen","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0280","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152710791556131","article-title":"Transgenic mouse models of tauopathy in drug discovery","volume":"9","author":"Noble","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0285","first-page":"104","article-title":"Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease","volume":"10","author":"Nunes","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0290","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1172\/JCI45194","article-title":"Glycogen synthase kinase-3 is essential for beta-arrestin-2 complex formation and lithium-sensitive behaviors in mice","volume":"121","author":"O'Brien","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0295","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0300","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0305","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","article-title":"Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1","volume":"23","author":"Ohno","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0310","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fnagi.2014.00162","article-title":"Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice","volume":"6","author":"Patel","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0315","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1091\/mbc.E12-12-0858","article-title":"Amyloid-beta oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons","volume":"24","author":"Ramser","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1471-4159.2008.05716.x","article-title":"Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation","volume":"108","author":"Sadik","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.07080.x","article-title":"CREB: a multifaceted regulator of neuronal plasticity and protection","volume":"116","author":"Sakamoto","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0330","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.bbadis.2014.04.011","article-title":"Insulin therapy modulates mitochondrial dynamics and biogenesis, autophagy and tau protein phosphorylation in the brain of type 1 diabetic rats","volume":"1842","author":"Santos","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/rns.2011.018","article-title":"The role of CREB signaling in Alzheimer's disease and other cognitive disorders","volume":"22","author":"Saura","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0340","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/ijms15010895","article-title":"Luteolin reduces Alzheimer's disease pathologies induced by traumatic brain injury","volume":"15","author":"Sawmiller","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0345","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2011.11.009","article-title":"Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics","volume":"83","author":"Scott Bitner","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","article-title":"Behavioral and EEG changes in male 5xFAD mice","volume":"135","author":"Schneider","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2013.03.051","article-title":"Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3beta\/tau signaling pathway and the Abeta formation prevention in rats","volume":"710","author":"Song","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0360","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/ALN.0000000000000278","article-title":"Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3beta activation in young mice","volume":"121","author":"Tao","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0365","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fncel.2013.00189","article-title":"Recent developments of protein kinase inhibitors as potential AD therapeutics","volume":"7","author":"Tell","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0370","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0375","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neurobiolaging.2006.10.016","article-title":"Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease","volume":"29","author":"Van Broeck","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0380","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1523\/JNEUROSCI.19-13-05360.1999","article-title":"Mutant presenilin-1 induces apoptosis and downregulates Akt\/PKB","volume":"19","author":"Weihl","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0385","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.2004.02737.x","article-title":"A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide\u2014the first step of a fatal cascade","volume":"91","author":"Wirths","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0390","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/1871527311312030016","article-title":"Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation","volume":"12","author":"Xiong","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2017.05.010_bb0395","first-page":"482","article-title":"Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease","volume":"2009","author":"Zhao","year":"1792","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616304122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616304122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T18:04:15Z","timestamp":1569348255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584616304122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":79,"alternative-id":["S0278584616304122"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}